Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Hypotension | Case Report

A loss-of-function AGTR1 variant in a critically-ill infant with renal tubular dysgenesis: case presentation and literature review

Authors: Aljazi Al-Maraghi, Waleed Aamer, Mubarak Ziab, Elbay Aliyev, Najwa Elbashir, Sura Hussein, Sasirekha Palaniswamy, Dhullipala Anand, Donald R. Love, Adrian Charles, Ammira A.S.Akil, Khalid A. Fakhro

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Renal tubular dysgenesis (RTD) is a severe disorder with poor prognosis significantly impacting the proximal tubules of the kidney while maintaining an anatomically normal gross structure. The genetic origin of RTD, involving variants in the ACE, REN, AGT, and AGTR1 genes, affects various enzymes or receptors within the Renin angiotensin system (RAS). This condition manifests prenatally with oligohydramninos and postnatally with persistent anuria, severe refractory hypotension, and defects in skull ossification.

Case presentation

In this report, we describe a case of a female patient who, despite receiving multi vasopressor treatment, experienced persistent hypotension, ultimately resulting in early death at five days of age. While there was a history of parental consanguinity, no reported family history of renal disease existed. Blood samples from the parents and the remaining DNA sample of the patient underwent Whole Genome Sequencing (WGS). The genetic analysis revealed a rare homozygous loss of function variant (NM_000685.5; c.415C > T; p.Arg139*) in the Angiotensin II Receptor Type 1 (AGTR1) gene.

Conclusion

This case highlights the consequence of loss-of-function variants in AGTR1 gene leading to RTD, which is characterized by high mortality rate at birth or during the neonatal period. Furthermore, we provide a comprehensive review of previously reported variants in the AGTR1 gene, which is the least encountered genetic cause of RTD, along with their associated clinical features.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allanson JE, Pantzar JT, Macleod PM. Possible new autosomal recessive syndrome with unusual renal histopathological changes. Am J Med Genet. 1983;16(1):57–60.CrossRefPubMed Allanson JE, Pantzar JT, Macleod PM. Possible new autosomal recessive syndrome with unusual renal histopathological changes. Am J Med Genet. 1983;16(1):57–60.CrossRefPubMed
2.
go back to reference Tseng M-H, Huang S-M, Huang J-L, Fan W-L, Konrad M, Shaw SW, et al. Autosomal Recessive Renal Tubular Dysgenesis Caused by a Founder Mutation of Angiotensinogen. Kidney Int Rep. 2020;5(11):2042–51.CrossRefPubMedPubMedCentral Tseng M-H, Huang S-M, Huang J-L, Fan W-L, Konrad M, Shaw SW, et al. Autosomal Recessive Renal Tubular Dysgenesis Caused by a Founder Mutation of Angiotensinogen. Kidney Int Rep. 2020;5(11):2042–51.CrossRefPubMedPubMedCentral
3.
go back to reference Vincent KM, Alrajhi A, Lazier J, Bonin B, Lawrence S, Weiler G, et al. Expanding the clinical spectrum of autosomal-recessive renal tubular dysgenesis: two siblings with neonatal survival and review of the literature. Mol Genet Genomic Med. 2022;10(5):e1920.CrossRefPubMedPubMedCentral Vincent KM, Alrajhi A, Lazier J, Bonin B, Lawrence S, Weiler G, et al. Expanding the clinical spectrum of autosomal-recessive renal tubular dysgenesis: two siblings with neonatal survival and review of the literature. Mol Genet Genomic Med. 2022;10(5):e1920.CrossRefPubMedPubMedCentral
5.
go back to reference Kumar D, Moss G, Primhak R, Coombs R. Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors. J Med Genet. 1997;34(7):541–5.CrossRefPubMedPubMedCentral Kumar D, Moss G, Primhak R, Coombs R. Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors. J Med Genet. 1997;34(7):541–5.CrossRefPubMedPubMedCentral
6.
go back to reference Gubler MC, Antignac C. Renin–angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int. 2010;77(5):400–6.CrossRefPubMed Gubler MC, Antignac C. Renin–angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int. 2010;77(5):400–6.CrossRefPubMed
7.
go back to reference McDonough AA. Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R851–61.CrossRefPubMedPubMedCentral McDonough AA. Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R851–61.CrossRefPubMedPubMedCentral
8.
go back to reference Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet. 2005;37(9):964–8.CrossRefPubMed Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet. 2005;37(9):964–8.CrossRefPubMed
9.
go back to reference Gribouval O, Morinière V, Pawtowski A, Arrondel C, Sallinen S-L, Saloranta C, et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat. 2012;33(2):316–26.CrossRefPubMed Gribouval O, Morinière V, Pawtowski A, Arrondel C, Sallinen S-L, Saloranta C, et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat. 2012;33(2):316–26.CrossRefPubMed
10.
go back to reference Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2007;112(8):417–28.CrossRefPubMed Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2007;112(8):417–28.CrossRefPubMed
11.
go back to reference Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, et al. Angiotensin-(1–7) is a modulator of the human renin-angiotensin system. Hypertens (Dallas, Tex 1979). 1999;34(2):296–301.CrossRef Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, et al. Angiotensin-(1–7) is a modulator of the human renin-angiotensin system. Hypertens (Dallas, Tex 1979). 1999;34(2):296–301.CrossRef
12.
go back to reference Zhang S-L, Moini B, Ingelfinger JR. Angiotensin II Increases Pax-2 Expression in Fetal Kidney Cells Via the AT2 Receptor. J Am Soc Nephrol. 2004;15(6):1452–65.CrossRefPubMed Zhang S-L, Moini B, Ingelfinger JR. Angiotensin II Increases Pax-2 Expression in Fetal Kidney Cells Via the AT2 Receptor. J Am Soc Nephrol. 2004;15(6):1452–65.CrossRefPubMed
13.
go back to reference Fakhro KA, Robay A, Rodrigues-Flores JL, Mezey JG, Al-Shakaki AA, Chidiac O, et al. Point of care exome sequencing reveals allelic and phenotypic heterogeneity underlying Mendelian disease in Qatar. Hum Mol Genet. 2019;28(23):3970–81.PubMed Fakhro KA, Robay A, Rodrigues-Flores JL, Mezey JG, Al-Shakaki AA, Chidiac O, et al. Point of care exome sequencing reveals allelic and phenotypic heterogeneity underlying Mendelian disease in Qatar. Hum Mol Genet. 2019;28(23):3970–81.PubMed
14.
go back to reference Da’as SI, Aamer W, Hasan W, Al-Maraghi A, Al-Kurbi A, Kilani H, et al. PGAP3 Associated with hyperphosphatasia with mental retardation plays a novel role in brain morphogenesis and neuronal wiring at early development. Cells. 2020;9(8):1782.CrossRefPubMedPubMedCentral Da’as SI, Aamer W, Hasan W, Al-Maraghi A, Al-Kurbi A, Kilani H, et al. PGAP3 Associated with hyperphosphatasia with mental retardation plays a novel role in brain morphogenesis and neuronal wiring at early development. Cells. 2020;9(8):1782.CrossRefPubMedPubMedCentral
15.
go back to reference Lacoste M, Cai Y, Guicharnaud L, Mounier F, Dumez Y, Bouvier R, et al. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system. J Am Soc Nephrol. 2006;17(8):2253–63.CrossRefPubMed Lacoste M, Cai Y, Guicharnaud L, Mounier F, Dumez Y, Bouvier R, et al. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system. J Am Soc Nephrol. 2006;17(8):2253–63.CrossRefPubMed
16.
go back to reference Viering DHHM, Bech AP, de Baaij JHF, Steenbergen EJ, Danser AHJ, Wetzels JFM, et al. Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor. Pediatr Nephrol. 2021;36(9):2731–7.CrossRefPubMedPubMedCentral Viering DHHM, Bech AP, de Baaij JHF, Steenbergen EJ, Danser AHJ, Wetzels JFM, et al. Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor. Pediatr Nephrol. 2021;36(9):2731–7.CrossRefPubMedPubMedCentral
17.
go back to reference Demirgan EB, Saygili S, Canpolat N, Sever L, Kilicaslan I, Taylan D, et al. AGTR1-related renal tubular dysgeneses may not be fatal. Kidney Int reports. 2021;6(3):846–52.CrossRef Demirgan EB, Saygili S, Canpolat N, Sever L, Kilicaslan I, Taylan D, et al. AGTR1-related renal tubular dysgeneses may not be fatal. Kidney Int reports. 2021;6(3):846–52.CrossRef
18.
go back to reference Banuelos R, Mallawaarachchi A, Doyle H, Mogra R. Oligohydramnios or anhydramnios and ultrasonically normal renal echotexture secondary to autosomal recessive renal tubular dysgenesis: an important consideration in the prenatal setting. Fetal Diagn Ther. 2023;50(1):17–21.CrossRefPubMed Banuelos R, Mallawaarachchi A, Doyle H, Mogra R. Oligohydramnios or anhydramnios and ultrasonically normal renal echotexture secondary to autosomal recessive renal tubular dysgenesis: an important consideration in the prenatal setting. Fetal Diagn Ther. 2023;50(1):17–21.CrossRefPubMed
Metadata
Title
A loss-of-function AGTR1 variant in a critically-ill infant with renal tubular dysgenesis: case presentation and literature review
Authors
Aljazi Al-Maraghi
Waleed Aamer
Mubarak Ziab
Elbay Aliyev
Najwa Elbashir
Sura Hussein
Sasirekha Palaniswamy
Dhullipala Anand
Donald R. Love
Adrian Charles
Ammira A.S.Akil
Khalid A. Fakhro
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03569-z

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.